Early research (Phase 1)Looking for participantsNCT06043713
What this trial is testing
Autologous CD8+ and CD4+ Transgenic T Cells Expressing High Affinity KRASG12V Mutation-Specific T Cell Receptors (FH-A11KRASG12V-TCR) in Treating Patients With Metastatic Solid Tumor Cancers With KRAS G12V Mutations
Who this might be right for
Metastatic Malignant Solid Neoplasm
Fred Hutchinson Cancer Center 24